Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

The North America infertility testing & treatment market is projected to develop with a CAGR of 10.48% over the forecasted period of 2021 to 2028. The market growth of the region is primarily reinforced by changing lifestyles, improved effectiveness of fertility treatments, the rise in same-sex marriages, and the increased age of conception.

NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

North America Infertility Testing & Treatment Market by Gender ( Male (Male Infertility Testing ( Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer-assisted Semen Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others ) Male Infertility Treatment (Medication, Assisted Reproductive Technology & Varicocele Surgery)) (Female ( Female Infertility Testing ( Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others) Female Infertility Treatment ( IVF With ICSI, IUI, IVF Without ICSI, Surrogacy, Others)) Market by End-user ( Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) and by Geography.

Request free sample

Report Summary

The North America infertility testing & treatment market is projected to develop with a CAGR of 10.48% over the forecasted period of 2021 to 2028. The market growth of the region is primarily reinforced by changing lifestyles, improved effectiveness of fertility treatments, the rise in same-sex marriages, and the increased age of conception.
north-america-infertility-testing-and-treatment-market
The North America infertility testing & treatment market growth evaluation includes the assessment of the United States and Canada. The increasing infertility cases in the United States on account of declining fertility in women, in addition to growing middle-age pregnancies, play an important role in driving the country’s market. As a widely used approach, infertility testing and treatment assists single mothers, couples with infertility issues, and the LGBTQ community in procreation. Moreover, the rising trend of delayed pregnancies and the growing disposable income augment the demand for infertility testing and treatment in the United States.

Furthermore, technological developments surrounding IVF procedures and the increased expenditures further fuel the market growth. In this regard, the elimination of implanting multiple embryos during IVF has considerably reduced the number of twin births in the United States. However, the market is inhibited by increased costs, low awareness levels of IVF, and its complications. Hence, these factors are set to bolster the North America infertility testing & treatment market growth over the forecast years.

CooperSurgical, headquartered in the United States, is a medical device company offering surgical instruments, clinic and office products, labor and delivery products, as well as critical care products. The company’s surgical products include hysterectomy instruments, c-section retractors, pelvic procedure kits, hernia repair, self-retaining retractors, wound protection, laparoscopic instruments, and others.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Table of Contents

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • GROWING STRESS AND LIFESTYLE DISORDERS
        • INCREASED AGE OF CONCEPTION
        • INCREASING EFFECTIVENESS OF TREATMENTS
        • RISING GOVERNMENT SUPPORT
      • KEY RESTRAINTS
        • HIGH COST OF TESTING AND TREATMENT
        • INFERTILITY CONSIDERED A SOCIAL TABOO
        • POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • REGULATORY FRAMEWORK
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END-USERS
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
        • MALE INFERTILITY TREATMENT
          • MEDICATION
          • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • ADORFEM
        • BANGKOK IVF CENTER
        • COOK MEDICAL INC
        • COOPER SURGICAL
        • CREATE FERTILITY CENTRE
        • EMD GROUP (MERCK KGAA)
        • ENDO INTERNATIONAL PLC
        • ESCO MEDICAL
        • FERRING PHARMACEUTICALS
        • FERTILITY FIRST
        • FUJIFILM IRVINE SCIENTIFIC
        • GENEA LTD
        • HALOTECH DNA
        • HAMILTON THRONE LTD
        • IVFTECH
        • LABOTECT GMBH
        • OLYMPUS CORPORATION
        • PROGYNY
        • THERMO FISHER SCIENTIFIC INC
        • VITROLIFE AB

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT

    TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

    TABLE 3: REGULATORY FRAMEWORK

    TABLE 4: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: PROS AND CONS OF DNA SHARING METHODS

    TABLE 11: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 12: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 13: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 14: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 15: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 16: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 17: COST OF OVULATION TESTING KITS IN THE US

    TABLE 18: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 21: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 22: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 23: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 24: LIST OF MERGERS & ACQUISITIONS

    TABLE 25: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 26: LIST OF PARTNERSHIPS & AGREEMENTS

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: KEY BUYING CRITERIA

    FIGURE 6: VALUE CHAIN ANALYSIS

    FIGURE 7: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 8: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020

    FIGURE 10: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 12: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)

    FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION

    FIGURE 14: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020

    FIGURE 22: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 24: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020

    FIGURE 26: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020

    FIGURE 28: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)

    FIGURE 30: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

    FIGURE 31: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)

    FIGURE 32: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 33: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)

    FIGURE 34: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 35: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 36: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020

    FIGURE 37: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 38: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)

    FIGURE 39: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)

    FIGURE 40: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)

    FIGURE 41: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)

    FIGURE 42: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 43: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 44: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)

    FIGURE 45: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)

    FIGURE 46: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 47: UNITED STATES INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: CANADA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY GENDER
      • MALE
        • MALE INFERTILITY TESTING
          • DNA FRAGMENTATION
          • OXIDATIVE STRESS ANALYSIS
          • SPERM PENETRATION ASSAY
          • COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
          • SPERM AGGLUTINATION
          • MICROSCOPIC EXAMINATION
          • OTHERS
      • MALE INFERTILITY TREATMENT
        • MEDICATION
        • ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
      • FEMALE
        • FEMALE INFERTILITY TESTING
          • OVULATION TESTING
          • HYSTEROSALPINGOGRAPHY
          • LAPAROSCOPY
          • TRANSVAGINAL ULTRASOUND
          • OVARIAN RESERVE TESTING
          • HORMONAL LEVEL TESTING
          • OTHERS
        • FEMALE INFERTILITY TREATMENT
          • IVF WITH ICSI
          • IUI
          • IVF WITHOUT ICSI
          • SURROGACY
          • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      RELATED REPORTS

      Author: shalini amarnani